Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ran Nussbaum

Affiliations

  • Large Shareholder, Director at Keros Therapeutics Inc. (KROS), 2020-04-07
  • Director at Arqule Inc (ARQL), 2020-01-16
  • Director at Eloxx Pharmaceuticals Inc. (ELOX), 2019-06-26
  • Director at Prevail Therapeutics Inc. (PRVL), 2019-06-19
  • Director at Urogen Pharma Ltd. (URGN), 2019-06-05
  • Director at Vbi Vaccines Inc (VBIV), 2017-11-01
  • Director at Kite Pharma Inc. (KITE), 2017-10-06
  • Large Shareholder at Arno Therapeutics Inc (ARNI), 2016-09-08
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ARQL $9.75 36,923 Director 36,923 2019-06-27 Filing
ARQL $9.75 72,205 Director 1,882,690 2019-06-27 Filing
ARQL $9.75 65,016 Director 1,695,673 2019-06-27 Filing
ARQL $9.75 133,548 Director 3,482,224 2019-06-27 Filing
ELOX $9.00 24,000 Director 24,000 2019-06-24 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
KITE $56.08 24,070 Director 0 2015-06-02 Filing
KITE $55.27 200,604 Director 24,070 2015-06-02 Filing
KITE $57.38 7,800 Director 224,674 2015-06-01 Filing
KITE $56.44 3,754 Director 232,474 2015-06-01 Filing
KITE $55.05 69,206 Director 236,228 2015-06-01 Filing